Investigating the effect of rose vaginal gel on sexual function of postmenopausal wome
Not Applicable
- Conditions
- Sexual function.Menopausal and other perimenopausal disorders
- Registration Number
- IRCT20240630062289N1
- Lead Sponsor
- Kermanshah University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 44
Inclusion Criteria
At least one year has passed since the last menstrual period or having a hormone test with an FSH level greater than 40 international units
Obtaining a score of 28 or more from the FSFI questionnaire
Age between 45 and 65 years
Being married
Absence or history of uterine and breast cancer
Exclusion Criteria
Having uterine bleeding or spotting with an unknown cause
Vaginal infection requires treatment
Abnormalities of the genital system Under sex hormone therapy within 8 weeks before the study
Use of vaginal drugs or any lubricants at least 15 days before the study
Smoking (alcohol, cigarettes, hookah)
Body mass index more than 30 kg/m2
Cholestatic liver disorders, severe kidney failure, acute thromboembolism and high blood pressure
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Sexual function. Timepoint: before the start of the study, 2, 6 and 12 weeks after the intervention. Method of measurement: Female Sexual Function Index (FSFI) questionnaire.
- Secondary Outcome Measures
Name Time Method